NATURE’S SUNSHINE PRODUCTS, INC. Repayments of Related Party Debt
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Repayments of Related Party Debt of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2024-03-12
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of related party debt for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of related party debt for the quarter ending 2023-09-30 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of related party debt for the quarter ending 2023-06-30 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of related party debt for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of related party debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of related party debt for fiscal 2022 was $302.00K, a 66.33% decline from fiscal 2021.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of related party debt for fiscal 2021 was $897.00K, a 182.08% increase from fiscal 2020.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of related party debt for fiscal 2020 was $318.00K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $0.00 derived: sum of 2 quarters · filed 2024-03-12 | $0.00 derived: sum of 3 quarters · filed 2024-03-12 | $0.00 10-K · filed 2024-03-12 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $2.00K derived: sum of 4 quarters · filed 2024-03-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $2.00K derived: sum of 3 quarters · filed 2024-03-12 | $2.00K derived: sum of 4 quarters · filed 2024-03-12 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $2.00K derived: sum of 2 quarters · filed 2024-03-12 | $2.00K derived: sum of 3 quarters · filed 2024-03-12 | $2.00K derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $2.00K derived: sum of 2 quarters · filed 2024-03-12 | $2.00K derived: sum of 3 quarters · filed 2024-03-12 | $302.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $300.00K 10-Q · filed 2023-11-07 | $597.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $300.00K 10-Q · filed 2023-08-09 | $597.00K derived: sum of 3 quarters · filed 2023-08-09 | $1.20M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $300.00K 10-Q · filed 2023-05-09 | $597.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.20M derived: sum of 3 quarters · filed 2023-05-09 | $1.20M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $297.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $897.00K derived: sum of 2 quarters · filed 2023-03-16 | $897.00K derived: sum of 3 quarters · filed 2023-03-16 | $897.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $600.00K derived: sum of 2 quarters · filed 2022-11-03 | $600.00K 10-Q · filed 2022-11-03 | $675.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $75.00K derived: sum of 3 quarters · filed 2022-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | $75.00K derived: sum of 2 quarters · filed 2022-05-05 | ||
| 2020-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $318.00K 10-K · filed 2022-03-08 | ||
| 2020-09-30 | $243.00K 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $0.00 10-K · filed 2021-03-10 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |